Akebia Therapeutics (AKBA) Debt Ratio (2018 - 2025)
Historic Debt Ratio for Akebia Therapeutics (AKBA) over the last 8 years, with Q3 2025 value amounting to 0.13.
- Akebia Therapeutics' Debt Ratio fell 2934.48% to 0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13, marking a year-over-year decrease of 2934.48%. This contributed to the annual value of 0.18 for FY2024, which is 2219.53% up from last year.
- Latest data reveals that Akebia Therapeutics reported Debt Ratio of 0.13 as of Q3 2025, which was down 2934.48% from 0.14 recorded in Q2 2025.
- In the past 5 years, Akebia Therapeutics' Debt Ratio registered a high of 0.19 during Q4 2022, and its lowest value of 0.13 during Q3 2025.
- Its 5-year average for Debt Ratio is 0.16, with a median of 0.17 in 2023.
- Its Debt Ratio has fluctuated over the past 5 years, first surged by 5911.44% in 2021, then tumbled by 2934.48% in 2025.
- Over the past 5 years, Akebia Therapeutics' Debt Ratio (Quarter) stood at 0.18 in 2021, then grew by 0.71% to 0.19 in 2022, then dropped by 22.68% to 0.14 in 2023, then rose by 22.2% to 0.18 in 2024, then fell by 25.39% to 0.13 in 2025.
- Its Debt Ratio stands at 0.13 for Q3 2025, versus 0.14 for Q2 2025 and 0.15 for Q1 2025.